SEMA4C and non-small cell lung carcinoma: Our study not only makes a significant contribution to the understanding of the roles and molecular mechanisms of miR‐138, GIT1 and SEMA4C in NSCLC progression, but also the data may be translated into new therapeutics and/or prognostic biomarkers for NSCLC.